Page 8 - Noble Laureate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Noble laureate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Noble Laureate Today - Breaking & Trending Today

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by Arizona State Retirement System

Arizona State Retirement System raised its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 2.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 33,974 shares of the biopharmaceutical company’s stock after purchasing an additional 803 shares during the […] ....

United States , David Bartel , Pushkal Garg , Thomas Tuschl , Yvonne Greenstreet , Phillip Zamore , Alnylam Pharmaceuticals Stock Performance , Harvest Fund Management Co , Alnylam Pharmaceuticals Inc , Securities Exchange Commission , Alta Advisers Ltd , Quarter For Alnylam Pharmaceuticals , Guardian Wealth Advisors , Canaccord Genuity Group , Alnylam Pharmaceuticals , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals Company Profile , Ci Investments Inc , Arizona State Retirement System , Get Rating , State Retirement System , Wealth Advisors , Advisers Ltd , Harvest Fund Management , Exchange Commission , Genuity Group ,

118 Shares in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Purchased by ANTIPODES PARTNERS Ltd

ANTIPODES PARTNERS Ltd purchased a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 118 shares of the biopharmaceutical company’s stock, valued at approximately $28,000. A number of other institutional investors and hedge funds […] ....

Thomas Tuschl , Jeffreyv Poulton , Phillip Zamore , Pushkal Garg , David Bartel , News Ratings For Alnylam Pharmaceuticals Daily , Great West Life Assurance Co , Metlife Investment Management , Alnylam Pharmaceuticals Price Performance , Quarter For Alnylam Pharmaceuticals , Jpmorgan Chase Co , Raymond James Financial Services Advisors Inc , Insider Transactions At Alnylam Pharmaceuticals , Dimensional Fund Advisors , Alnylam Pharmaceuticals , Panagora Asset Management Inc , Alnylam Pharmaceuticals Inc , Morgan Stanley , Get Rating , James Financial Services Advisors , Life Investment Management , Asset Management , West Life Assurance , Fund Advisors , Noble Laureate , Alnylam Pharmaceuticals Daily ,

Alnylam Pharmaceuticals (NASDAQ:ALNY) Releases Quarterly Earnings Results, Beats Expectations By $0.57 EPS

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Rating) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.40) EPS for the quarter, beating the consensus estimate of ($1.97) by $0.57, Briefing.com reports. The firm had revenue of $319.29 million for the quarter, compared to the consensus estimate of $312.53 million. Alnylam Pharmaceuticals had a negative […] ....

Phillip Zamore , David Bartel , Pushkal Garg , Thomas Tuschl , Norges Bank , Vanguard Group Inc , Hedge Funds Weigh In On Alnylam Pharmaceuticals , News Ratings For Alnylam Pharmaceuticals Daily , Ef Hutton Acquisition Co , Alnylam Pharmaceuticals Inc , Invesco Ltd , Morgan Stanley , Securities Exchange Commission , Alnylam Pharmaceuticals Trading , Alnylam Pharmaceuticals , Earnings History For Alnylam Pharmaceuticals , Jpmorgan Chase Co , Get Rating , Exchange Commission , Lall Franchini , Vance Management , State Street Corp , Street Corp , Noble Laureate , Alnylam Pharmaceuticals Daily , Nasdaq Alny ,

Parametrica Management Ltd Sells 4,339 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Parametrica Management Ltd cut its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 31.4% during the fourth quarter, HoldingsChannel reports. The fund owned 9,500 shares of the biopharmaceutical company’s stock after selling 4,339 shares during the quarter. Alnylam Pharmaceuticals comprises approximately 4.6% of Parametrica Management Ltd’s holdings, making the stock its 8th biggest […] ....

Phillip Zamore , David Bartel , Pushkal Garg , Thomas Tuschl , Invesco Ltd , Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Inc , Alnylam Pharmaceuticals Trading , Canaccord Genuity Group , Parametrica Management Ltd , Asset Management Americas Inc , Jpmorgan Chase Co , Nuveen Asset Management , Quarter For Alnylam Pharmaceuticals , News Ratings For Alnylam Pharmaceuticals Daily , Vanguard Group Inc , Get Rating , Management Ltd , Asset Management , Street Corp , Management Americas , Lall Franchini , Genuity Group , Noble Laureate , Visit Holdingschannel , Alnylam Pharmaceuticals Daily ,

PJT Partners (PJT) to Release Earnings on Tuesday

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) CEO Yvonne Greenstreet sold 7,615 shares of the stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $194.59, for a total value of $1,481,802.85. Following the transaction, the chief executive officer now directly owns 30,332 shares in the company, valued […] ....

Phillip Zamore , David Bartel , Yvonne Greenstreet , Thomas Tuschl , Sanfordc Bernstein , Canaccord Genuity Group , News Ratings For Alnylam Pharmaceuticals Daily , Belpointe Asset Management , Northwestern Mutual Wealth Management Co , Guardian Wealth Advisors , Hedge Funds Weigh In On Alnylam Pharmaceuticals , Quarter For Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Inc , Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Company Profile , Jpmorgan Chase Co , Alnylam Pharmaceuticals Price Performance , Get Rating , Genuity Group , Asset Management , Wealth Advisors , Northwestern Mutual Wealth Management , Mutual Wealth Management , Noble Laureate , Alnylam Pharmaceuticals Daily , Nasdaq Alny ,